Expression of Fas (CD95/APO-1) Ligand by Human Breast Cancers: Significance for Tumor Immune Privilege

Breast cancers have been shown to elicit tumor-specific immune responses. As in other types of cancer, the antitumor immune response fails to contain breast tumor growth, and a reduction in both the quantity and cytotoxic effectiveness of tumor-infiltrating lymphocytes (TILs) is associated with a po...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Clin Diagn Lab Immunol
Principais autores:	O’Connell, Joe, Bennett, Michael W., O’Sullivan, Gerald C., O’Callaghan, Jim, Collins, J. Kevin, Shanahan, Fergus
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC95708/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10391843/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.6.4.457-463.1999
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!